• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ImageIQ, IMARC Research form co-marketing partnership

ImageIQ, IMARC Research form co-marketing partnership

April 29, 2013
CenterWatch Staff

ImageIQ, an imaging CRO based in Cleveland, Ohio, and IMARC Research, a Strongsville, Ohio-based CRO offering monitoring, auditing and training services, have formed a partnership that will strengthen the abilities of both organization’s clients to manage the complexities of imaging within clinical trials, and to enhance FDA approvals by ensuring that scientific data is optimized and that processes are compliant.

IMARC will bring its 14 years of clinical trial management experience to ImageIQ clients that utilize ImageIQ’s imaging analytics and software development expertise. Conversely, ImageIQ will provide IMARC clients with their imaging and image analysis clinical trial expertise.

“Medical imaging technology and imaging analytics have changed vastly in the past few years, providing whole new strata of clinical trial data,” said Sandra Maddock, CEO and president of IMARC Research. “However, with the addition of various imaging modalities into a clinical trial comes increased complexities and risks that need to be considered and carefully monitored in order to ensure accurate, complete, and evaluable data at the end of the study.”

This partnership differentiates IMARC Research as a CRO that can accommodate those added complexities with various risk mitigation approaches including clinical trial monitoring, auditing, and Good Clinical Practice (GCP) training.

“Our clients often begin working with us on innovative ways to utilize imaging within clinical trials, to improve data quality, to quantify product marketing claims, and to strengthen FDA documentation,” said Tim Kulbago, CEO of ImageIQ. “As a part of that process, they quickly realize that imaging enhances the scientific results that they garner. It is also clear to them that adding imaging requires a sophisticated process to ensure imaging compliance monitoring and auditing process. Our clients are already very pleased that IMARC Research can provide that expertise.”

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing